专利检索 ap:("Amgen, Inc") AND inv:"JOHNSON, Eileen, J." 第 1 页

1.

发明授权
CGRP PEPTIDE ANTAGONISTS AND CONJUGATES 有权
标题翻译： CGRP肽拮抗剂和结合

公开(公告)号：EP1940452B1

公开(公告)日：2012-11-21

申请号：EP06826442.3

申请日：2006-10-20

申请人： Amgen, Inc

发明人： GEGG, Colin, V., Jr. , MIRANDA, Leslie, P. , WALKER, Kenneth, W. , JOHNSON, Eileen, J. , HOLDER, Jerry, Ryan , WRIGHT, Marie, E. , D'AMICO, Derin, C.

IPC分类号： A61K38/22 , C07K14/575 , A61P25/06

CPC分类号： A61K38/225 , C07K14/57527

2.

发明公开
CGRP PEPTIDE ANTAGONISTS AND CONJUGATES 有权
标题翻译： CGRP肽拮抗剂和结合

公开(公告)号：EP1940452A2

公开(公告)日：2008-07-09

申请号：EP06826442.3

申请日：2006-10-20

申请人： Amgen, Inc

发明人： GEGG, Colin, V., Jr. , MIRANDA, Leslie, P. , WALKER, Kenneth, W. , JOHNSON, Eileen, J. , HOLDER, Jerry, Ryan , WRIGHT, Marie, E. , D'AMICO, Derin, C.

IPC分类号： A61K38/22 , C07K14/575 , A61P25/06

CPC分类号： A61K38/225 , C07K14/57527

摘要： Disclosed is a composition of matter that involves a CGRP peptide antagonist. A pharmaceutical composition is disclosed that comprises the composition of matter and a pharmaceutically acceptable carrier, which can be configured for administration to a patient. Also disclosed is a method of producing the composition of matter. Methods of treating, preventing or mitigating migraine, are also disclosed.